CITIUS PHARMACEUTICALS INC

CUSIP: 17322U207 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 1,878,953 Value ($000) $941 Avg Close Range
Q2 2024
Shares 1,646,297 Value ($000) $961 Avg Close Range
Q1 2024
Shares 2,945,494 Value ($000) $2,643 Avg Close Range
Q4 2023
Shares 2,779,908 Value ($000) $2,103 Avg Close Range
Q3 2023
Shares 2,675,375 Value ($000) $1,831 Avg Close Range
Q2 2023
Shares 2,608,033 Value ($000) $3,130 Avg Close Range
Q1 2023
Shares 1,338,777 Value ($000) $1,566 Avg Close Range
Q4 2022
Shares 1,332,623 Value ($000) $1 Avg Close Range
Q3 2022
Shares 1,323,296 Value ($000) $1,601 Avg Close Range
Q2 2022
Shares 1,310,059 Value ($000) $1,205 Avg Close Range
Q1 2022
Shares 2,272,145 Value ($000) $4,067 Avg Close Range
Q4 2021
Shares 2,049,218 Value ($000) $3,155 Avg Close Range
Q3 2021
Shares 2,131,122 Value ($000) $4,326 Avg Close Range
Q2 2021
Shares 1,905,508 Value ($000) $6,631 Avg Close Range
Q1 2021
Shares 854,207 Value ($000) $1,520 Avg Close Range
Q4 2020
Shares 144,949 Value ($000) $147 Avg Close Range
Q3 2020
Shares 144,949 Value ($000) $150 Avg Close Range
Q2 2020
Shares 69,247 Value ($000) $78 Avg Close Range